

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | £0.66 | £318.89 £239.17 Free shipping | |
| 270 pills | £0.74 | £267.22 £200.41 Free shipping | |
| 180 pills | £0.83 | £199.30 £149.48 Free shipping | |
| 120 pills | £0.97 | £156.49 £117.36 | |
| 90 pills | £1.00 | £119.58 £89.68 | |
| 60 pills | £1.11 | £88.57 £66.43 | |
| 30 pills | £1.41 | £56.09 £42.07 | |
| 360 pills | £1.02 | £488.68 £366.51 Free shipping | |
| 270 pills | £1.07 | £386.81 £290.11 Free shipping | |
| 180 pills | £1.12 | £268.69 £201.52 Free shipping | |
| 120 pills | £1.18 | £188.97 £141.73 | |
| 90 pills | £1.26 | £152.06 £114.04 | |
| 60 pills | £1.35 | £107.76 £80.82 | |
| 30 pills | £1.58 | £63.47 £47.60 | |
| 360 pills | £1.57 | £754.44 £565.83 Free shipping | |
| 270 pills | £1.65 | £593.51 £445.13 Free shipping | |
| 180 pills | £1.74 | £417.81 £313.36 Free shipping | |
| 120 pills | £1.82 | £290.84 £218.13 Free shipping | |
| 90 pills | £1.95 | £233.26 £174.94 Free shipping | |
| 60 pills | £2.08 | £166.82 £125.12 | |
| 30 pills | £2.23 | £88.57 £66.43 |
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that increases synaptic serotonin by inhibiting the serotonin transporter. It is primarily indicated for the treatment of major depressive disorder and generalized anxiety disorder. This pharmacologic profile supports relief of core affective and anxiety symptoms in adults and, under professional supervision, in select younger patients.
Pharmacodynamically, escitalopram is the active S-enantiomer of citalopram with a favorable receptor profile and tolerability in many patients. It achieves steady-state exposure after several days of daily dosing and is extensively metabolized in the liver with renal clearance of the parent compound and metabolites. Clinically, onset of mood and anxiety symptom improvement is typically observed over several weeks, with continued treatment often required to sustain benefit.
Escitalopram is approved for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). In routine practice, patients may experience reductions in depressive symptoms, improved anxiety control, and better overall function as the medication takes effect. Clinicians monitor for changes in mood, sleep, appetite, and activity levels during the initial weeks of therapy.
While the primary indications are MDD and GAD, clinicians may consider escitalopram in selected cases of other anxiety-related disorders under professional supervision. Dosing and monitoring are tailored to the individual patient, taking into account comorbid conditions, concomitant medications, and risk of adverse effects. Safety in pregnancy and lactation requires careful discussion between patient and prescriber.
The usual starting dose for adults is 10 mg once daily. Depending on therapeutic response and tolerability, the dose may be increased to a maximum of 20 mg daily. In older adults or individuals with hepatic impairment, initiation at lower doses (for example, 5 mg daily) is common with cautious titration. Dosing decisions are individualized and should be guided by clinical response and side effects.
Escitalopram may be taken with or without food. If sleep disturbance occurs, taking the dose in the morning can help; if sedation is troublesome, taking it in the evening may be preferable. Consistency in daily timing optimizes tolerability and may improve adherence. Patients should avoid abrupt dose changes or stopping the medication without consulting a clinician, as withdrawal symptoms can occur with rapid discontinuation.
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double up to make up for a missed dose. If several days have passed, resume the prescribed schedule and discuss any concerns with a clinician. Concomitant use with monoamine oxidase inhibitors (MAOIs) or other serotonergic agents requires careful medical supervision due to the risk of serotonin syndrome; follow clinician guidance about washout periods if transitioning therapies.
Storage should be in a controlled environment at room temperature (typically 20–25°C, with excursions allowed per local guidelines). Keep tablets in their original container, away from moisture and heat, and out of reach of children and pets. Do not use expired medication. Pregnant or breastfeeding individuals should discuss risks and benefits with a clinician before continuing therapy, as needed. Regular follow-up appointments are advised to monitor efficacy and adverse effects during dose adjustments.
Common side effects include nausea, dry mouth, insomnia or sleepiness, headache, fatigue, increased sweating, and sexual dysfunction. Appetite or weight changes and mild dizziness may also occur, particularly during the first weeks of treatment. These effects are often transient and may lessen with time or after dose adjustments.
Serious adverse events are less common but require prompt medical attention. Seek care if you experience signs of serotonin syndrome (agitation, confusion, fever, tremor, sweating, rapid heart rate), uncontrolled movements, or severe changes in mental status. Hyponatremia can present with confusion, seizures, or unsteadiness, especially in older adults. Long-term bleeding risk may be modestly increased with concomitant antiplatelet or nonsteroidal anti-inflammatory drugs. If mood worsens, thoughts of self-harm, or new or escalating agitation occur, contact a clinician promptly. If a rash, facial swelling, or difficulty breathing develops, seek urgent medical care as a possible allergic reaction may be present.
Consult a clinician promptly if there is worsening depressive or anxious symptoms, new or intensified suicidal thoughts, or behavior changes, particularly in younger patients or those with prior mood disorders. Signs of serotonin syndrome, such as high fever, confusion, muscle rigidity, or seizures, require urgent evaluation. Seek medical attention for chest pain, shortness of breath, severe headaches, or unusual bleeding or bruising.
Ongoing care is advised if there is no meaningful improvement after about 4–6 weeks of therapy at a therapeutic dose, or if tolerability issues prevent continued treatment. Before changing or stopping escitalopram, discuss a taper plan with a clinician to minimize withdrawal symptoms. Inform all healthcare providers about escitalopram use to prevent potential drug interactions, particularly with MAOIs, anticoagulants, antiplatelets, NSAIDs, and other serotonergic medicines.
14–21 days. Free from £147.64 .
5–9 days. £22.15
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
